Key Takeaways:
- Aehr Test Systems (AEHR, Financial) is significantly shorted, indicating potential volatility or investor skepticism.
- Analysts provide uniformly optimistic price targets, suggesting confidence in the company’s strategic direction.
- The GF Value assessment points to substantial potential upside based on historical and projected metrics.
Aehr Test Systems (AEHR) is currently one of the most heavily shorted stocks in 2025, with around 24.1% of its shares shorted. Specializing in semiconductor test technology, Aehr Test Systems is strategically expanding its business into the realms of AI processors and silicon carbide power semiconductors. This move positions the company to capitalize on significant growth opportunities within rapidly evolving technology markets.
Wall Street Analysts Forecast
According to price targets from 1 analyst, the average target price for Aehr Test Systems stands at $19.00, with both the high and low estimates aligning at $19.00. This figure suggests an impressive potential upside of 180.24% from the current share price of $6.78. For more comprehensive analysis, refer to the Aehr Test Systems (AEHR, Financial) Forecast page.
Wall Street brokerages have issued a consensus recommendation rating of 2.5 for Aehr Test Systems, classifying it as an "Outperform." This ranking is derived from a rating scale where 1 represents a Strong Buy and 5 signifies a Sell.
Moreover, GuruFocus's valuation metrics project an estimated GF Value for Aehr Test Systems at $25.01 in the coming year, indicating a potential upside of 268.88% from the current stock price of $6.78. The GF Value is GuruFocus's calculated assessment of a stock's fair trading value, derived from historical trading multiples, past growth, and anticipated future performance metrics. Additional details are available on the Aehr Test Systems (AEHR, Financial) Summary page.
